Fonte: Journal of Clinical Oncology. Unidade: FM
Assuntos: LINFOMA (TERAPIA), MEDICAÇÃO INTRAVENOSA, ANTINEOPLÁSICOS (ADMINISTRAÇÃO E DOSAGEM)
ABNT
SALAR, Antonio et al. Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study. Journal of Clinical Oncology, v. 32, n. 17, p. 1782-1791, 2014Tradução . . Disponível em: https://doi.org/10.1200/JCO.2013.52.2631. Acesso em: 21 out. 2024.APA
Salar, A., Avivi, I., Bittner, B., Bouabdallah, R., Brewster, M., Catalani, O., et al. (2014). Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study. Journal of Clinical Oncology, 32( 17), 1782-1791. doi:10.1200/JCO.2013.52.2631NLM
Salar A, Avivi I, Bittner B, Bouabdallah R, Brewster M, Catalani O, Follows G, Haynes A, Hourcade-Potelleret F, Janikova A, Larouche J-F, McIntyre C, Pedersen M, Pereira J, Sayyed P. Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study [Internet]. Journal of Clinical Oncology. 2014 ; 32( 17): 1782-1791.[citado 2024 out. 21 ] Available from: https://doi.org/10.1200/JCO.2013.52.2631Vancouver
Salar A, Avivi I, Bittner B, Bouabdallah R, Brewster M, Catalani O, Follows G, Haynes A, Hourcade-Potelleret F, Janikova A, Larouche J-F, McIntyre C, Pedersen M, Pereira J, Sayyed P. Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study [Internet]. Journal of Clinical Oncology. 2014 ; 32( 17): 1782-1791.[citado 2024 out. 21 ] Available from: https://doi.org/10.1200/JCO.2013.52.2631